The physical findings in persons meeting the Canadian definition may signal the presence of a neurologic condition considered exclusionary for CFS and thus the XMRV positive persons in the Lombardi et al. study may represent
a clinical subset of patients [11].
Not exact matches
The result is a genomically defined
subset of patients with a clear likelihood
of clinical improvement.
Cancer immunotherapy can produce durable
clinical responses, but only in a
subset of patients.
This study involved a
subset of patients enrolled in a
clinical trial
of pediatric AML called AML02.
A
clinical trial studying the use
of Verapamil (a drug currently in use for cardiovascular disease and cluster headache) in alleviating chronic rhinosinusitis (CRS) with nasal polyps revealed significant improvement in the symptoms
of this
subset of patients.
«First - line immunotherapy treatment can improve survival for
subset of lung cancer
patients: Results
of phase III global
clinical trial show that 75 percent
of stage IV lung cancer
patients with both complex tumor mutations and PDL - 1 positive status respond to nivolumab.»
In a randomized, phase 2 multi-center
clinical study, led by Manisha Shah, MD
of The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James), investigators tested the effectiveness
of the targeted therapy drug, dabrafenib (pronounced «da bRAF e nib» and marketed as Tafinlar), given alone compared with the same drug given in combination with trametinib (pronounced «tra ME ti nib,» marketed at MeKinist) to treat a
subset of advanced papillary thyroid cancer
patients with B - raf mutations.
Yet research and
clinical observations over the past 40 years have raised concerns that these drugs produce suicidal thoughts, suicide attempts and possibly even suicide in a small
subset of depressed
patients.
The study enrolled 100
patients with de novo coronary lesions 2.25 - 3.50 mm in diameter and length ≤ 27 mm in two 50 -
patient cohorts for angiographic, intravascular ultrasound, and
clinical assessment at nine or 24 months, with optical coherence tomography (OCT) performed in a
subset of 30
patients at multiple time periods.
The paper, «Perturbations in the lipid profile
of individuals with newly diagnosed type 1 diabetes mellitus: lipidomics analysis
of a Diabetes Antibody Standardization Program sample
subset,» published in
Clinical Biochemistry, described lipidomics (see sidebar) analyses
of blood samples from
patients recently diagnosed with type 1 diabetes mellitus (T1DM).
Overall, despite the dramatic therapeutic advances made elsewhere in the melanoma field, the poor prognosis
of patients with mucosal melanoma mandates continued emphasis on laboratory and
clinical research efforts in this rare
subset of disease.
[44] Two other phase II
clinical trials evaluated the efficacy
of imatinib in
patients with melanoma — including mucosal melanomas — harboring KIT mutations and / or amplifications, with a
subset of cases involving mucosal primaries, and both found a disease control rate
of approximately 50 %.
The third paper in the issue
of the Journal
of Clinical Oncology describes an analysis
of a very rare
subset of patients with low - stage disease and amplification
of the MYCN oncogene.
Within the
subset of 23
patients that were in the higher dose cohorts and would qualify for the Toca 5 trial,
patients had a median survival
of 14.4 months and 43.5 % (10/23)
of patients had
clinical benefit (5 complete responses and 5 stable disease
patients).
All
of the case series studies showed improvements in
clinical measures, which indicates that these outcomes can be obtained in the outpatient practice setting in at least a
subset of adherent
patients.
In concurrent studies, the team will examine the gene expression profile
of subsets of patients with different
clinical outcomes to provide further insight into why certain dogs have more aggressive B - CLL and to identify possible drug targetable pathways to improve the treatment for this cancer.
The
subset of clinical neuropsychology applies this knowledge to help in the assessment, diagnosis, and treatment
of patients that have cognitive disorders, learning disabilities, neurological or psychiatric conditions, and physical or developmental issues that have cognitive or mental repercussions.